Effects of pre-analytical processes on blood samples used in metabolomics studies

Analytical and Bioanalytical Chemistry

Volumn 407, Issue 17, 2015, Pages 4879-4892

  Yin, Peiyuan ^a   Lehmann, Rainer ^b,c,d   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Bias; Biobank; Blood; Liquid chromatography mass spectrometry; Metabolomics; Plasma; Preanalytical; Serum; Standard operation procedure; Urine

Indexed keywords

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMAS;

BIAS; BIOBANK; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; METABOLOMICS; OPERATION PROCEDURE; PREANALYTICAL; SERUM; URINE;

BLOOD;

BLOOD SAMPLING; BLOOD STORAGE; CHEMISTRY; CRYOPRESERVATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLOME; METABOLOMICS; PLASMA; PROCEDURES; SERUM;

BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, LIQUID; CRYOPRESERVATION; HUMANS; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; PLASMA; SERUM;

EID: 84924198791     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-015-8565-x     Document Type: Review

References (109)

1. Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding themetabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11):1181-1189
2. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu JD, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao XH, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231):910-914
3. Lokhov PG, Dashtiev MI, Moshkovskii SA, Archakov AI (2010) Metabolite profiling of blood plasma of patients with prostate cancer. Metabolomics 6(1):156-163
4. Huang Q, Tan YX, Yin PY, Ye GZ, Gao P, Lu X,Wang HY, Xu GW (2013) Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics. Cancer Res 73(16):4992-5002
5. Duarte IF, Rocha CM, Gil AM (2013) Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis. Expert Rev Mol Diagn 13(7):737-748
6. Vuckovic D (2012) Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry. Anal Bioanal Chem 403(6):1523-1548
7. Kinross JM, Holmes E, Darzi AW, Nicholson JK (2011) Metabolic phenotyping for monitoring surgical patients. Lancet 377(9780):1817-1819
8. Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, Chen T, Su M, Zhao A, Jia W (2011) Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 129(9):2207-2217
9. Cuevas-Cordoba B, Santiago-Garcia J (2014) Saliva: a fluid of study for OMICS. OMICS 18(2):87-97
10. Alvarez-Sanchez B, Priego-Capote F, Luque de Castro MD (2012) Study of sample preparation for metabolomic profiling of human saliva by liquid chromatography-time of flight/mass spectrometry. J Chromatogr A 1248:178-181
11. Ibanez C, Simo C, Barupal DK, Fiehn O, Kivipelto M, Cedazo-Minguez A, Cifuentes A (2013) A new metabolomic workflow for early detection of Alzheimer’s disease. J Chromatogr A 1302:65-71
12. Trushina E, Dutta T, Persson XM,Mielke MM, Petersen RC (2013) Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer’s disease using metabolomics. PLoS One 8(5):e63644
13. Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK, Chen G, Guitart X, Carlson PJ, Neumeister A, Zarate C, Krishnan RR, Manji HK, Drevets W (2012) Cerebrospinal fluid metabolome in mood disordersremission state has a unique metabolic profile. Sci Rep 2:667
14. Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A (2011) Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res 10(9):4208-4218
15. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R (2014) Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis 35(9):2089-2096
16. Ng Hublin JS, Ryan U, Trengove R, Maker G (2013) Metabolomic profiling of faecal extracts from Cryptosporidium parvum infection in experimental mouse models. PLoS One 8(10):e77803
17. O’Gorman A, Wallace M, Cottell E, Gibney MJ, McAuliffe FM, Wingfield M, Brennan L (2013) Metabolic profiling of human follicular fluid identifies potential biomarkers of oocyte developmental competence. Reproduction 146(4):389-395
18. Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P (2009) Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 7:40
19. Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS (2013) The human urine metabolome. PLoS One 8(9):e73076
20. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48:653-683
21. Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B (2005) Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr 82(3):497-503
22. Wishart DS (2008) Applications of metabolomics in drug discovery and development. Drugs R D 9(5):307-322
23. Holland NT, Pfleger L, Berger E, Ho A, Bastaki M (2005) Molecular epidemiology biomarkers - Sample collection and processing considerations. Toxicol Appl Pharm 206(2):261-268
24. Leyland-Jones BR, Ambrosone CB, Bartlett J, Ellis MJ, Enos RA, Raji A, Pins MR, Zujewski JA, Hewitt SM, Forbes JF, Abramovitz M, Braga S, Cardoso F, Harbeck N, Denkert C, Jewell SD, Breast International G, Cooperative Groups of the Breast Cancer Intergroup of North A, American College of Surgeons Oncology G, Cancer, Leukemia Group B, Eastern Cooperative Oncology G, North Central Cancer Treatment G, National Cancer Institute of Canada Clinical Trials G, Southwest Oncology G, National Surgical Adjuvant B, Bowel P, Radiation Oncology G, Gynecologic Oncology G, Children’s Oncology G (2008) Recommendations for collection and handling of specimens from group breast cancer clinical trials. J Clin Oncol 26(34):5638-5644
25. Yin P, Peter A, Franken H, Zhao X, Neukamm SS, Rosenbaum L, Lucio M, Zell A, Haring HU, Xu G, Lehmann R (2013) Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem 59(5):833-845
26. Guder WG (2014) History of the preanalytical phase: a personal view. Biochemia Med 24(1):25-30
27. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39(9):1764-1779
28. Cooper GR, Myers GL, Smith SJ, Sampson EJ (1988) Standardization of lipid, lipoprotein, and apolipoprotein measurements. Clin Chem 34(8B):B95-B105
29. Delanghe J, Speeckaert M (2014) Preanalytical requirements of urinalysis. Biochemia Med 24(1):89-104
30. Ament Z, Masoodi M, Griffin JL (2012) Applications of metabolomics for understanding the action of peroxisome proliferatoractivated receptors (PPARs) in diabetes, obesity and cancer. Genome Med 4(4):32
31. van der Greef J, van Wietmarschen H, van Ommen B, Verheij E (2013) Looking back into the future: 30 years of metabolomics at TNO. Mass Spectrom Rev 32(5):399-415
32. Griffin JL, Atherton H, Shockcor J, Atzori L (2011) Metabolomics as a tool for cardiac research. Nat Rev Cardiol 8(11):630-643
33. Abu Aboud O, Weiss RH (2013) New Opportunities from the Cancer Metabolome. Clin Chem 59(1):138-146
34. Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical Applications of Metabolomics in Oncology: A Review. Clin Cancer Res 15(2):431-440
35. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O’Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448-453
36. Yin P, Xu G (2013) Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry. Expert Rev Mol Diagn 13(4):339-348
37. Chen J, Zhang XY, Cao R, Lu X, Zhao SM, Fekete A, Huang Q, Schmitt-Kopplin P,Wang YS, Xu ZL,Wan XP,Wu XH, Zhao NQ, Xu CJ, Xu GW (2011) Serum 27-nor-5 beta-Cholestane-3,7,12,24, 25 Pentol Glucuronide Discovered by Metabolomics as Potential Diagnostic Biomarker for Epithelium Ovarian Cancer. J Proteome Res 10(5):2625-2632
38. Gika H, Theodoridis G (2011) Sample preparation prior to the LCMS- based metabolomics/metabonomics of blood-derived samples. Bioanalysis 3(14):1647-1661
39. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, van Ommen B, Smilde AK (2006) Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 78(2):567-574
40. Eichner J, Rosenbaum L, Wrzodek C, Haring H-U, Zell A, Lehmann R (2014) Integrated enrichment analysis and pathwaycentered visualization of metabolomics, proteomics, transcriptomics, and genomics data by using the InCroMAP software. J Chromatogr B Analyt Technol Biomed Life Sci 966:77-82
41. Minami Y, Kasukawa T, Kakazu Y, Iigo M, Sugimoto M, Ikeda S, Yasui A, van der Horst GT, Soga T, Ueda HR (2009) Measurement of internal body time by blood metabolomics. Proc Natl Acad Sci U S A 106(24):9890-9895
42. Weigert C, Lehmann R, Hartwig S, Lehr S (2014) The secretome of the working human skeletal muscle-a promising opportunity to combat the metabolic disaster? Proteomics Clin Appl 8(1-2):5-18
43. Griffin JL, Bollard ME (2004) Metabonomics: its potential as a tool in toxicology for safety assessment and data integration. Curr Drug Metab 5(5):389-398
44. Narayanan S (2000) The preanalytic phase. An important component of laboratory medicine. Am J Clin Pathol 113(3):429-452
45. Ishikawa M, Maekawa K, Saito K, Senoo Y, Urata M, Murayama M, Tajima Y, Kumagai Y, Saito Y (2014) Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects’ gender and age. PLoS One 9(3):e91806
46. Ishikawa M, Tajima Y, Murayama M, Senoo Y, Maekawa K, Saito Y (2013) Plasma and serum from nonfasting men and women differ in their lipidomic profiles. Biol Pharm Bull 36(4):682-685
47. Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, Hanson RW, Kalhan SC, Ryals JA, Milburn MV (2008) Analysis of the adult human plasma metabolome. Pharmacogenomics 9(4):383-397
48. Chan YC, Suzuki M, Yamamoto S (1999) A comparison of anthropometry, biochemical variables and plasma amino acids among centenarians, elderly and young subjects. J Am Coll Nutr 18(4):358-365
49. Morris C, O’Grada C, Ryan M, Roche HM, Gibney MJ, Gibney ER, Brennan L (2012) The relationship between BMI and metabolomic profiles: a focus on amino acids. Proc Nutr Soc 71(4):634-638
50. Kochhar S, Jacobs DM, Ramadan Z, Berruex F, Fuerholz A, Fay LB (2006) Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal Biochem 352(2):274-281
51. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS Jr, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9(4):311-326
52. Lucio M, Fekete A,Weigert C,Wagele B, Zhao X, Chen J, Fritsche A, Haring H-U, Schleicher ED, Xu G, Schmitt-Kopplin P, Lehmann R (2010) Insulin sensitivity is reflected by characteristic metabolic fingerprints-a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One 5(10):e13317
53. Brauer R, Leichtle AB, Fiedler GM, Thiery J, Ceglarek U (2011) Preanalytical standardization of amino acid and acylcarnitine metabolite profiling in human blood using tandem mass spectrometry. Metabolomics 7(3):344-352
54. Simundic AM, Cornes M, Grankvist K, Lippi G, Nybo M (2014) Standardization of collection requirements for fasting samples: For the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chim Acta 432:33-37
55. Gooley JJ, Chua EC (2014) Diurnal Regulation of Lipid Metabolism and Applications of Circadian Lipidomics. J Genet Genomics 41(5):231-250
56. Ang JE, Revell V, Mann A, Mantele S, Otway DT, Johnston JD, Thumser AE, Skene DJ, Raynaud F (2012) Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach. Chronobiol Int 29(7):868-881
57. Kasukawa T, Sugimoto M, Hida A,Minami Y, Mori M, Honma S, Honma K-i, Mishima K, Soga T, Ueda HR (2012) Human blood metabolite timetable indicates internal body time. Proc Natl Acad Sci U S A 109(37):15036-15041
58. Lehmann R, Zhao X,Weigert C, Simon P, Fehrenbach E, Fritsche J, Machann J, Schick F, Wang J, Hoene M, Schleicher ED, Haring HU, Xu G, Niess AM (2010) Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation. PLoS One 5(7):e11519
59. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S, Greiner R, Sykes BD,Marrie TJ (2007) Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79(18):6995-7004
60. Gillio-Meina C, Cepinskas G, Cecchini EL, Fraser DD (2013) Translational research in pediatrics II: blood collection, processing, shipping, and storage. Pediatrics 131(4):754-766
61. Winnike JH, Busby MG,Watkins PB, O’Connell TM (2009) Effects of a prolonged standardized diet on normalizing the human metabolome. Am J Clin Nutr 90(6):1496-1501
62. Pechlivanis A, Kostidis S, Saraslanidis P, Petridou A, Tsalis G, Veselkov K, Mikros E, Mougios V, Theodoridis GA (2013) 1H NMR study on the short- and long-term impact of two training programs of sprint running on the metabolic fingerprint of human serum. J Proteome Res 12(1):470-480
63. Hsu PC, Zhou B, Zhao Y, Ressom HW, Cheema AK, Pickworth W, Shields PG (2013) Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS. J Proteome Res 12(2):679-691
64. Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA (2012) The human circadian metabolome. Proc Natl Acad Sci U S A 109(7):2625-2629
65. Mei H, Hsieh Y, Nardo C, Xu X, Wang S, Ng K, Korfmacher WA (2003) Investigation of matrix effects in bioanalytical highperformance liquid chromatography/tandem mass spectrometric assays:application to drug discovery. Rapid CommunMass Spectrom 17(1):97-103
66. Koulman A, Prentice P, Wong MC, Matthews L, Bond NJ, Eiden M, Griffin JL, Dunger DB (2014) The development and validation of a fast and robust dried blood spot based lipid profiling method to study infant metabolism. Metabolomics 10(5):1018-1025
67. Kong ST, Lin HS, Ching J, Ho PC (2011) Evaluation of Dried Blood Spots as Sample Matrix for Gas Chromatography/Mass Spectrometry Based Metabolomic Profiling. Anal Chem 83(11):4314-4318
68. Gucciardi A, Pirillo P,DiGangi IM, Naturale M, Giordano G (2012) A rapid UPLC-MS/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a secondtier test for expanded newborn screening. Anal Bioanal Chem 404(3):741-751
69. Michopoulos F, Theodoridis G, Smith CJ, Wilson ID (2010) Metabolite Profiles from Dried Biofluid Spots for Metabonomic Studies using UPLC Combined with oaToF-MS. J Proteome Res 9(6):3328-3334
70. Michopoulos F, Theodoridis G, Smith CJ, Wilson ID (2011) Metabolite profiles from dried blood spots for metabonomic studies using UPLC combined with orthogonal acceleration ToF-MS: effects of different papers and sample storage stability. Bioanalysis 3(24):2757-2767
71. Barri T, Dragsted LO (2013) UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Anal Chim Acta 768:118-128
72. Ladenson JH, Tsai LM, Michael JM, Kessler G, Joist JH (1974) Serum versus heparinized plasma for eighteen common chemistry tests: is serum the appropriate specimen? Am J Clin Pathol 62(4):545-552
73. Yu Z, Kastenmuller G, He Y, Belcredi P, Moller G, Prehn C, Mendes J, Wahl S, Roemisch-Margl W, Ceglarek U, Polonikov A, Dahmen N, Prokisch H, Xie L, Li Y, Wichmann HE, Peters A, Kronenberg F, Suhre K, Adamski J, Illig T, Wang-Sattler R (2011) Differences between human plasma and serum metabolite profiles. PLoS One 6(7):e21230
74. Lin Z, Zhang Z, Lu H, Jin Y, Yi L, Liang Y (2014) Joint MS-based platforms for comprehensive comparison of rat plasma and serum metabolic profiling. Biomed Chromatogr 28(9):1235-1245
75. Liu L, Aa J,Wang G, Yan B, Zhang Y,Wang X, Zhao C, Cao B, Shi J, Li M, Zheng T, Zheng Y, Hao G, Zhou F, Sun J, Wu Z (2010) Differences in metabolite profile between blood plasma and serum. Anal Biochem 406(2):105-112
76. Wedge DC, Allwood JW, Dunn W, Vaughan AA, Simpson K, Brown M, Priest L, Blackhall FH, Whetton AD, Dive C, Goodacre R (2011) Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer. Anal Chem 83(17):6689-6697
77. Dettmer K, Almstetter MF, Appel IJ, Nurnberger N, Schlamberger G, Gronwald W, Meyer HH, Oefner PJ (2010) Comparison of serum versus plasma collection in gas chromatography-mass spectrometry-based metabolomics. Electrophoresis 31(14):2365-2373
78. Denery JR, Nunes AAK, Dickerson TJ (2011) Characterization of differences between blood sample matrices in untargeted metabolomics. Anal Chem 83(3):1040-1047
79. Barelli S, Crettaz D, Thadikkaran L, Rubin O, Tissot J-D (2007) Plasma/serum proteomics: pre-analytical issues. Expert Rev Proteomics 4(3):363-370
80. Issaq HJ, Xiao Z, Veenstra TD (2007) Serum and plasma proteomics. Chem Rev 107(8):3601-3620
81. Wung WE, Howell SB (1980) Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma. Clin Chem 26(12):1704-1708
82. Denery JR, Nunes AA, Dickerson TJ (2011) Characterization of differences between blood sample matrices in untargeted metabolomics. Anal Chem 83(3):1040-1047
83. Nicholson JK, Buckingham MJ, Sadler PJ (1983) High resolution 1H n.m.r. studies of vertebrate blood and plasma. BiochemJ 211(3):605-615
84. Theil PK, Pedersen LJ, Jensen MB, Yde CC, Bach Knudsen KE (2012) Blood sampling and hemolysis affect concentration of plasma metabolites. J Anim Sci 90(Suppl 4):412-414
85. Agarwal S, Vargas G, Nordstrom C, Tam E, Buffone GJ, Devaraj S (2014) Effect of interference from hemolysis, icterus and lipemia on routine pediatric clinical chemistry assays. Clin Chim Acta 438C:241-245
86. Gimenez-Marin A, Rivas-Ruiz F, Perez-Hidalgo Mdel M, Molina-Mendoza P (2014) Pre-analytical errors management in the clinical laboratory: a five-year study. Biochem Med (Zagreb) 24(2):248-257
87. Ji JZ, Meng QH (2011) Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays. Clin Chim Acta 412(17-18):1550-1553
88. Timms JF, Arslan-Low E, Gentry-Maharaj A, Luo Z, T’Jampens D, Podust VN, Ford J, Fung ET, Gammerman A, Jacobs I, Menon U (2007) Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. Clin Chem 53(4):645-656
89. Teahan O, Gamble S, Holmes E, Waxman J, Nicholson JK, Bevan C, Keun HC (2006) Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem 78(13):4307-4318
90. Kamlage B, Maldonado SG, Bethan B, Peter E, Schmitz O, Liebenberg V, Schatz P (2014) Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin Chem 60(2):399-412
91. Yang W, Chen Y, Xi C, Zhang R, Song Y, Zhan Q, Bi X, Abliz Z (2013) Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites’ stability on reliability of potential biomarkers. Anal Chem 85(5):2606-2610
92. Pinto J, Domingues MR, Galhano E, Pita C, Almeida MD, Carreira IM, Gil AM (2014) Human plasma stability during handling and storage: impact on NMR metabolomics. Analyst 139(5):1168-1177
93. Cuhadar S, Koseoglu M, Atay A, Dirican A (2013) The effect of storage time and freeze-thaw cycles on the stability of serum samples. Biochem Med (Zagreb) 23(1):70-77
94. Mitchell BL, Yasui Y, Li CI, Fitzpatrick AL, Lampe PD (2005) Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects. Cancer Informat 1:98-104
95. Vaught JB (2006) Blood collection, shipment, processing, and storage. Cancer Epidemiol Biomarkers Prev 15(9):1582-1584
96. Hustad S, Eussen S,Midttun O, Ulvik A, van de Kant PM,Morkrid L, Gislefoss R, Ueland PM (2012) Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 58(2):402-410
97. Metherel AH, Henao JJA, Stark KD (2013) EPA and DHA Levels in Whole Blood Decrease More Rapidly when Stored at -20 degrees C as Compared with Room Temperature, 4 and -75 degrees C. Lipids 48(11):1079-1091
98. Pottala JV, Espeland MA, Polreis J, Robinson J, Harris WS (2012) Correcting the effects of -20 degrees C storage and aliquot size on erythrocyte fatty acid content in the Women’s Health Initiative. Lipids 47(9):835-846
99. Rai AJ, Stemmer PM, Zhang Z, Adam B-L, Morgan WT, Caffrey RE, Podust VN, Patel M, Lim L-Y, Shipulina NV, Chan DW, Semmes OJ, Leung H-CE (2005) Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers. Proteomics 5(13):3467-3474
100. Ross KS, Haites NE, Kelly KF (1990) Repeated freezing and thawing of peripheral blood and DNA in suspension: effects on DNAyield and integrity. J Med Genet 27(9):569-570
101. Fliniaux O, Gaillard G, Lion A, Cailleu D, Mesnard F, Betsou F (2011) Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks. J Biomol NMR 51(4):457-465
102. Comstock GW, Burke AE, Norkus EP, Gordon GB, Hoffman SC, Helzlsouer KJ (2001) Effects of repeated freeze-thaw cycles on concentrations of cholesterol, micronutrients, and hormones in human plasma and serum. Clin Chem 47(1):139-142
103. Michopoulos F, Lai L, Gika H, Theodoridis G, Wilson I (2009) UPLC-MS-Based Analysis of Human Plasma for Metabonomics Using Solvent Precipitation or Solid Phase Extraction. J Proteome Res 8(4):2114-2121
104. Want EJ (2006) Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem 78:743-752
105. Gika HG, Theodoridis GA, Wilson ID (2008) Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine. J Sep Sci 31(9):1598-1608
106. Chen S, Hoene M, Li J, Li Y, Zhao X, Haring HU, Schleicher ED, Weigert C, Xu G, Lehmann R (2013) Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography/mass spectrometry. J Chromatogr A 1298:9-16
107. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, Brown M, Knowles JD, Halsall A, Haselden JN, Nicholls AW, Wilson ID, Kell DB, Goodacre R (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6(7):1060-1083
108. Leichtle AB,Dufour JF, Fiedler GM (2013) Potentials and pitfalls of clinical peptidomics and metabolomics. Swiss Med Wkly 143:w13801
109. Helmschrodt C, Becker S, Thiery J, Ceglarek U (2014) Preanalytical standardization for reactive oxygen species derived oxysterol analysis in human plasma by liquid chromatography-tandem mass spectrometry. Biochem Biophys Res Commun 446(3):726-730